🍂 Enjoy the Fall Season! 🍂
MindTheDesk

Guggenheim Sets $62 Target on Bristol-Myers Squibb Company (BMY) After FDA Priority Review

Business Archived December 17, 2025
Guggenheim Sets $62 Target on Bristol-Myers Squibb Company (BMY) After FDA Priority Review
Source: https://finance.yahoo.com/rss/topstories - Read Original
"Adventure is where you chose to go."
"Free Quote Today"

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored